Literature DB >> 30661265

What should clinicians do as fentanyl replaces heroin?

Adam Bisaga1.   

Abstract

Entities:  

Keywords:  Buprenorphine; fentanyl; methadone; naloxone; naltrexone; opioid use disorder treatment; overdose prevention

Year:  2019        PMID： 30661265     DOI： 10.1111/add.14522

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  10 in total

1.  Street fentanyl use: Experiences, preferences, and concordance between self-reports and urine toxicology.

Authors:  Raminta Daniulaityte; Robert R Carlson; Matthew P Juhascik; Kraig E Strayer; Ioana E Sizemore
Journal:  Int J Drug Policy       Date:  2019-05-27

2.  Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case series.

Authors:  Daniel Shearer; Samantha Young; Nadia Fairbairn; Rupinder Brar
Journal:  Drug Alcohol Rev       Date:  2021-10-13

3.  Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl.

Authors:  Neil B Varshneya; Ashish P Thakrar; J Gregory Hobelmann; Kelly E Dunn; Andrew S Huhn
Journal:  J Addict Med       Date:  2021-11-23       Impact factor: 4.647

4.  Protracted renal clearance of fentanyl in persons with opioid use disorder.

Authors:  Andrew S Huhn; J Gregory Hobelmann; George A Oyler; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-07-02       Impact factor: 4.492

5.  A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.

Authors:  Mohammad Sibai; Kaitlyn Mishlen; Edward V Nunes; Frances R Levin; John J Mariani; Adam Bisaga
Journal:  Am J Drug Alcohol Abuse       Date:  2019-12-20       Impact factor: 3.829

6.  Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone.

Authors:  Denis Antoine; Andrew S Huhn; Eric C Strain; Gavin Turner; Jasmyne Jardot; Alexis S Hammond; Kelly E Dunn
Journal:  Am J Addict       Date:  2020-06-23

7.  Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease.

Authors:  Ryan R Cook; Randy Torralva; Caroline King; Paula J Lum; Hansel Tookes; Canyon Foot; Pamela Vergara-Rodriguez; Allan Rodriguez; Laura Fanucchi; Gregory M Lucas; Elizabeth N Waddell; P Todd Korthuis
Journal:  Drug Alcohol Depend       Date:  2021-09-20       Impact factor: 4.492

8.  Remotely delivered incentives to promote buprenorphine treatment engagement in out-of-treatment adults with opioid use disorder.

Authors:  August F Holtyn; Forrest Toegel; Matthew D Novak; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2021-05-27       Impact factor: 4.852

9.  Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis.

Authors:  Adams K K; Miech E J; Sobieraj D M
Journal:  Addict Sci Clin Pract       Date:  2022-10-04

Review 10.  The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.

Authors:  Ying Han; Wei Yan; Yongbo Zheng; Muhammad Zahid Khan; Kai Yuan; Lin Lu
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.